Close Menu

USAMRIID

NEW YORK (GenomeWeb) – An American team led by researchers at the US Army Medical Research Institute of Infectious Diseases (USAMRIID) has come up with a proposed set of standards for investigators sequencing and assembling viral genomes.

ZyGem said today that it has signed a cooperative research and development agreement with the US Army Medical Research Institute of Infectious Diseases to develop simplified sample processing tools for biothreat agent detection.

Biomatrica and USAMRIID will collaborate to develop, test, validate, and eventually commercialize new formulations designed to stabilize clinical samples and biological agents at ambient conditions.

The company also released its 2010 financial results, posting a jump in its net loss despite increased revenues.

The agreement provides Akonni access to nucleic acid sequences, primers, and probes for several important biothreat agents, which it will incorporate into molecular tests on its TruArray and TruSentry platforms.

Pages

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.